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Adenovirus-mediated suppression 
of hypothalamic glucokinase 
affects feeding behavior
Romina María Uranga1,3, Carola Millán1,4, María José Barahona1, Antonia Recabal1, Magdiel 
Salgado1, Fernando Martinez1, Patricio Ordenes1, Roberto Elizondo-Vega1, Fernando 
Sepúlveda1, Elena Uribe2 & María de los Ángeles García-Robles  1
Glucokinase (GK), the hexokinase involved in glucosensing in pancreatic β-cells, is also expressed in 
arcuate nucleus (AN) neurons and hypothalamic tanycytes, the cells that surround the basal third 
ventricle (3V). Several lines of evidence suggest that tanycytes may be involved in the regulation of 
energy homeostasis. Tanycytes have extended cell processes that contact the feeding-regulating 
neurons in the AN, particularly, agouti-related protein (AgRP), neuropeptide Y (NPY), cocaine- and 
amphetamine-regulated transcript (CART) and proopiomelanocortin (POMC) neurons. In this study, 
we developed an adenovirus expressing GK shRNA to inhibit GK expression in vivo. When injected into 
the 3V of rats, this adenovirus preferentially transduced tanycytes. qRT-PCR and Western blot assays 
confirmed GK mRNA and protein levels were lower in GK knockdown animals compared to the controls. 
In response to an intracerebroventricular glucose injection, the mRNA levels of anorexigenic POMC and 
CART and orexigenic AgRP and NPY neuropeptides were altered in GK knockdown animals. Similarly, 
food intake, meal duration, frequency of eating events and the cumulative eating time were increased, 
whereas the intervals between meals were decreased in GK knockdown rats, suggesting a decrease 
in satiety. Thus, GK expression in the ventricular cells appears to play an important role in feeding 
behavior.
As one of the main centers controlling food intake, the hypothalamus is a structure located in the basal region of 
the third ventricle (3V), and is composed of neurons (grouped in different nuclei) and other cells, such as tany-
cytes, that respond to glucose concentration1–4. Tanycytes are specialized ependymal cells that cover the lower 
lateral walls and the floor of the 3V. Morphologically, tanycytes are polarized, lengthened cells with apical surface 
differentiations in direct contact with the cerebrospinal fluid (CSF) and long basal processes that come into close 
contact with neurons from the periventricular nuclei of the basal hypothalamus5. Based on their morphological 
and histochemical features, tanycytes have been classified into four subpopulations: α1, α2, β1 and β26. α2 and 
β1 tanycytes are localized in the lower lateral wall of the 3V. Importantly, they have extended cell processes that 
project into the arcuate nucleus (AN) and appear to come into close contact with feeding-regulating neurons, par-
ticularly agouti-related protein (AgRP), neuropeptide Y (NPY), cocaine- and amphetamine-regulated transcript 
(CART) and proopiomelanocortin (POMC) neurons7, 8. β2 tanycytes are located in the floor of the 3V. lining the 
median eminence (ME). These cells develop tight junctions that form the CSF-ME barrier. The proximal part of 
the cells is in contact with the CSF whereas the distal part of the cells forms processes in which the end feet reach 
the local capillary plexus in the ME. Although the specific roles of tanycytes in the hypothalamus are still under 
debate, their strategic proximity to and relationship with fenestrated capillaries, the blood brain barrier, axonal 
nerve terminals, and hypothalamic nuclei that regulate appetite/energy expenditure has placed them in a privi-
leged position to integrate multiple inputs and regulate homeostasis9.
The pancreas, liver and small intestine are specialized organs, which respond to changes in blood glucose lev-
els. The presence of glucose transporter 2 (GLUT2) and glucokinase (GK, hexokinase IV) enables glucosensing 
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cells to detect blood glucose levels10, 11. We and others have previously demonstrated that tanycytes express several 
proteins involved in the peripheral glucosensing mechanisms, such as GK (the pancreatic isoform), GLUT2 and 
the pore-forming subunit of ATP-sensitive potassium channels, Kir6.112–14.
In addition to expression, GK activity has been observed in tanycytes (S0.5 of 10 mM)15. Thus, it is the presence 
of this functional isoform of GK, together with GLUT2, that makes it possible for tanycytes to sense and respond 
to glucose changes with increased intracellular calcium in a mechanism that involves GK activity3. The fact that 
GK knock-out mice die a few days after birth due to acute hyperglycemia highlights the vital role of GK16, 17. 
Millán et al.18 reported hypothalamic GK to be expressed mainly in α and β tanycytes; GK expression was weak 
in neurons and absent in astrocytes18. Similarly, Salgado et al.15 cloned GK expressed in tanycytes and demon-
strated its functionality. However, there is enough information that validates its location in hypothalamic neu-
rons19–22. Additionally, GLUT2 is expressed in hypothalamic tanycytes12. Interestingly, hypothalamic AN neurons 
do not express GLUT2; however, they are connected to nerve endings from GLUT2-expressing neurons23. On the 
other hand, GLUT2 is so well-located in the nucleus of solitary tract in neurons, and there is no evidence of glia 
expression in this brain region24. Recent evidence obtained after molecular and pharmacological activation of GK 
in rats cannulated into the AN shows that GK activity specifically regulates glucose intake and dietary glucose 
uptake25. Expression of glucokinase regulatory protein (GKRP), a known GK inhibitor with a critical metabolic 
role in hepatocytes26, has also been demonstrated in tanycytes15. The presence of GKRP in tanycytes reinforces 
the importance of GK activity in these cells.
Over the last five decades, it has been suggested that glucose availability may regulate food intake. Despite 
the considerable efforts invested in unraveling the molecular mechanisms related to hypothalamic glucosensing 
and satiety response, there are still many unanswered questions. Here, we show that injection of an adenovirus 
expressing short hairpin RNA (shRNA) targeting GK into the 3V generates specific transduction of ependymal 
glia, especially tanycytes. GK knockdown animals showed no variation in NPY and AgRP (orexigenic neuropep-
tides) and CART (anorexigenic). POMC (another anorexigenic neuropeptide) showed to be even decreased in 
response to glucose when GK was knocked down. In conclusion, knockdown animals lost the normal response to 
glucose (i.e. a decrease in orexigenic neuropeptides and an increase in anorexigenic neuropeptides). In addition, 
alterations in feeding behavior (i.e., decreased satiety) were detected. Based on these results, we postulate that 
hypothalamic GK activity could regulate food intake as part of a glucostatic control system.
Results
Ad-shGK-EGFP injection into the basal 3V. Since the success in GK knockdown depends upon the 
efficiency of adenoviral transduction, time-course studies were carried out in order to determine the time point 
at which there was a maximal infection rate. We analyzed EGFP fluorescence levels in rat brain slices at 18, 
24 and 48 h post-i.c.v. injection of the recombinant adenovirus and compared them with levels of the tanycyte 
marker, vimentin, by immunostaining (Fig. 1). At 12 h post-injection, a faint signal from EGFP was detected in 
a few α-tanycytes (data not shown). At 18 h after i.c.v. injection, EGFP expression was detected in ventricular 
cells with elongated processes, which due to their location, correspond to α-tanycytes (Fig. 1A, arrow), which 
are vimentin-positive (Fig. 1B,C). High fluorescence was detected in the proximal region and basal processes 
of vimentin-positive cells at 24 h after injection (Fig. 1D–F). High levels of fluorescence were still observed for 
at least 48 h post-i.c.v. injection in ependymal cells (1), α-tanycytes, (2), β1-tanycytes (3) and β2-tanycytes (4) 
(Fig. 1G). Higher magnification images are shown in Fig. 1H and I. Importantly, EGFP fluorescence was limited 
to tanycytes, and no transduction of other areas was observed. EGFP was detected in the cell bodies and pro-
cesses of cells lining the infundibular recess, which according to their location, correspond to α and β1-tanycytes. 
Particularly, the colocalization of Ad-EGFP with vimentin (shown in yellow) became more evident in β2-tany-
cytes (Fig. 1G–I).
EGFP fluorescence was detected in cells whose localization and morphological features are suggestive 
of tanycytes. We evaluated astrocyte transduction in a three dimensional reconstruction of 20 focal planes 
(Supplementary Fig. S1). Sections of the basal hypothalamus from transduced animals were analyzed by spectral 
confocal microscopy for detecting EGFP fluorescence (green) and the astrocyte markers, GFAP (blue) and vimen-
tin (red). EGFP expression was detected in the ventricular cells having long cellular processes, which due to their 
location, are α- and β-tanycytes. The expression of GFAP and vimentin was also detectable in the same region, 
where a different distribution of both proteins was clearly observed. In agreement with previous results27, GFAP 
was mainly detected in the subependymal region of the ME. Analysis of the co-expression of EGFP and GFAP at 
higher magnification revealed no co-expression of both proteins. However, a clear co-distribution of EGFP and 
vimentin was observed in the proximal region (arrowhead) and processes of tanycytes (arrows). Because adenovi-
ruses can cause gliosis, which favors the incorporation of adenovirus by reactive astrocytes, we next evaluated the 
colocalization of both glial markers using a focal plane and Pearson’s correlation analysis. Colocalization of EGFP 
with vimentin was detected in the ventricular area (Fig. 2B,E, arrows) and in several cell processes (Fig. 2B,E, 
arrowheads). The Rr value estimated for EGFP/vimentin colocalization was 0.47 ± 0.11 in the area of α-tanycytes 
(Fig. 2B), whereas the Rr value for EGFP/GFAP colocalization in the same region was 0.18 ± 0.02, suggesting that 
EGFP colocalized to a larger extent with vimentin as compared with GFAP (Fig. 2C). Intense EGFP and vimen-
tin colocalization (yellow) was observed in β-tanycytes (Fig. 2E, arrows) and the long fine processes contacting 
AN neurons (Fig. 2E, arrowheads). In this region, the Rr value estimated for EGFP/vimentin colocalization was 
0.53 ± 0.06, whereas the Rr value estimated for EGFP/GFAP colocalization was 0.01 ± 0.02 (Fig. 2F). Astrocytes 
located in the proximity of α-tanycytes were strongly positive for GFAP, but not for EGFP (Fig. 2C, asterisks). The 
absence of transduction was detected also in astrocytes located in the proximity of β1-tanycytes and β2-tanycytes 
from the ME (Fig. 2F, asterisks). Although other authors have reported the serotype 5 adenoviruses transduces 
astrocytes, our results suggest that if adenovirus is injected in the 3V, it preferentially transduced tanycytes and 
not astrocytes. We used the neuronal marker, NeuN, and the tanycyte marker, vimentin, to evaluate neuronal 
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transduction (Fig. 3A–E). EGFP was absent in NeuN-positive neurons (Fig. 3C,E), suggesting that AN neurons 
were not transduced with the adenovirus. Additionally, we analyzed the EGFP fluorescence in other cerebral 
regions, such as the cortex, hippocampus, and choroidal plexus, and compared it with that observed in the ven-
tricular walls of the same animals. The intensity of EGFP fluorescence was systematically different in the tanycyte 
population with most fluorescence detected in β2-tanycytes then α-tanycytes and slightly lower in β1-tanycytes. 
Figure 1. Time-course of adenoviral transduction in the basal hypothalamus. (A–L) Frontal sections (40 µm) 
from the hypothalamus at 18 h (A–C), 24 h (D–F) and 48 h (G–I) following injection of adenoviral particles 
(Ad-shGK-EGFP) into the 3V. EGFP fluorescence (green) and immunoreactivity for vimentin (red) and 
colocalization of EGFP and vimentin (yellow) are shown. Arrows show the processes of transduced tanycytes. 
(G) Panoramic view of the basal hypothalamus, showing tanycyte transduction. (I) Higher magnification image 
showing that Ad-EGFP transduction occurs in β2-tanycytes. AN, arcuate nucleus; 3V, third ventricle; ME, 
median eminence. Scale bars (A–F and H) 50 µm, (G) 100 µm, (I) 20 µm.
www.nature.com/scientificreports/
4Scientific RepoRts | 7: 3697  | DOI:10.1038/s41598-017-03928-x
Similar to β2-tanycytes, EGFP was detected in 3V-ependymal cells with weak signal observed in the choroid 
plexus and no signal detected in the cortex and hippocampus (Supplementary Fig. S2).
In vivo GK inhibition by adenoviral injection into the 3V. We evaluated GK expression in total hypo-
thalamic protein extracts at 48 h post-transduction using Western blot analysis of hypothalamic samples from 
rats injected with Ad-shβGal-EGFP or Ad-shGK-EGFP. As shown in Fig. 4A, GK expression was found to be 
significantly decreased (75%) in rats injected with AdshGK-EGFP with respect to Ad-shβGal-EGFP-injected 
rats. We also evaluated whether GLUT2 expression, which is also present in tanycytes12, was altered by GK inhi-
bition. We detected no significant differences in protein levels between both animal groups, demonstrating the 
specificity of the GK shRNA (Fig. 4B). Similarly, GKRP, which is also expressed in tanycytes15, was not affected by 
GK inhibition (Fig. 4C). EGFP was detected at similar levels in rats transduced with both adenoviruses (Fig. 4D). 
The intensity of the bands was normalized to β-actin and expressed as a percentage of the ratio obtained with the 
control. Thus, only GK expression was significantly decreased following injection of the adenovirus carrying the 
shGK-RNA, and no compensatory effects on GLUT2 or GKRP expression occur under these conditions. Finally, 
immunohistochemistry analysis in the basal hypothalamus in both Ad- shGK and Ad-shβgal using anti-GK and 
anti-vimentin antibodies demonstrated a minor degree of GK fluorescence in GK knockdown animals. In these 
animals, GK-associated fluorescence was only decreased in vimentin-positive cells; no differences were detected 
in AN neurons (Supplementary Fig. S3).
Effect of GK knockdown on neuropeptide expression in response to i.c.v. glucose injection. It 
has been previously shown that a 50 mM glucose stimulus directly into the 3V generates a neuronal response 
mediated by changes in the expression of anorexigenic and orexigenic neuropeptides28. Here, we tested if this 
glucose-triggered response was maintained in rats following GK knockdown. At 48 h after transduction, rats were 
subjected to a 24-h fasting period. Control and GK knockdown rats were next i.c.v. injected with 50 mM D-glucose 
(or saline). At 2 h after the glucose challenge, the expression of feeding-regulatory neuropeptides was analyzed by 
qRT-PCR (Fig. 5A–D). After glucose injection, control rats (Ad-shβGal-EGFP) showed a 50% and 70% decrease 
in the orexigenic peptides, NPY and AgRP, respectively (Fig. 5A,B, respectively) with respect to saline treatment. 
In contrast, a 70% and 200% increase in the anorexigenic peptides, POMC and CART, respectively, was observed 
in glucose-injected control rats compared to saline-injected control rats (Fig. 5C,D, respectively). This decrease 
in orexigenic neuropeptides and increase in anorexigenic neuropeptides is the expected normal response to glu-
cose29. However, when saline and glucose treatment responses were compared in GK knockdown animals, no 
Figure 2. Distribution of EGFP in hypothalamic glial cells. (A–F) Representative confocal images of one 
focal plane using anti-vimentin (red) or anti-GFAP (red) antibodies as well as the fluorescence associated with 
EGFP (green) and the nuclear marker, TOPRO-3 (blue). (A–C) Adenoviral transduction in α-tanycytes. (D–F) 
Adenoviral transduction of β-tanycytes. (A,C) EGFP detected in apical membranes (arrows) and in long cellular 
processes in the basal hypothalamus (arrowheads). (B,E) Vimentin showing both proximal (arrows) and distal 
(arrowheads) tanycyte regions and colocalization with the EGFP. (C,F) GFAP showing astrocyte distribution, 
the absence of GFAP in the ventricular wall (arrows) and EGFP-positive processes (arrowheads). Scale bars 
(A–H) 50 µm.
www.nature.com/scientificreports/
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Figure 3. Co-distribution of EGFP and the neuronal marker, NeuN, in the basal hypothalamus. (A–E) 
Representative confocal images of one focal plane using anti-vimentin (red) or anti-NeuN (red) antibodies 
as well as EGFP fluorescence (green) and TOPRO-3 (blue). (A) Image showing EGFP in an α-/β-tanycyte 
transition region. (B) EGFP detected in the proximal (arrows) and distal processes (arrowheads) of vimentin-
positive α-and β-tanycytes. (C) The neuronal marker, NeuN, distribution (red), showing the absence of 
colocalization with EGFP. (D,E) High magnification image of the area shown in (B and C). Scale bars (A–C) 
50 μm; (D,E) 25 μm.
Figure 4. GK inhibition 48 h after AdshGK injection into the 3V. (A) Western blot assays of hypothalamic 
protein extracts in control (Ad-shβGal-injected rats) and Ad-shGK-injected rats using anti-GK, anti-GLUT2, 
anti-GKRP, and anti-GFP (transduction control) antibodies. An anti-β-actin antibody was used as loading 
control. Images are representative of three different experiments. (B) Densitometric analysis of each protein 
relative to β-actin evaluated in Ad-shGK-injected rats, as a percentage of this protein in Ad-shβgal-EGFP-
injected rats. Statistics: t-test with Welch correction *p < 0.05.
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statistically significant differences were detected in orexigenic neuropeptides (Fig. 5A,B). Regarding anorexi-
genic neuropeptides, CART expression showed no difference between saline-injected and glucose-injected GK 
knockdown animals (Fig. 5D). However, POMC expression was decreased in glucose-injected GK knockdown 
animals compared to saline-injected GK knockdown animals (Fig. 5C). Saline-injected animals (control and 
GK-inhibited) showed significant differences in anorexigenic neuropeptides, which suggest that GK could be 
participating in the normal response to starvation. These results clearly indicate that GK knockdown animals lost 
the glucose-regulated expression of feeding-regulating neuropeptides.
Effect of hypothalamic GK knockdown on food intake and feeding behavior. After confirming 
that the GK gene was preferently knocked down in tanycytes cells, we sought to investigate whether it caused any 
alteration in the amount of food intake. At the top of the Fig. 6 the experimental procedure is showing. As shown 
in Fig. 6A, GK knockdown animals showed a significant increase in food intake over 12 h compared to both 
control groups. Specifically, GK knockdown animals ate 16 g of food pellet, whereas AdshβGal-EGFP-injected 
animals ate 11 g; unoperated animals ate 10 g. No significant differences were detected when comparing both 
control groups (unoperated and Ad-shβGal-EGFP).
To further address a role of GK in feeding behavior, the time that three group of animals spent eating (after 
fasting) was measured using a system that allowed individual register ad libitum feeding and daily recording of 
food intake. During the first meal, unoperated animals spent 22 ± 8 min eating, and Ad-shβGal-EGFP-injected 
animals spent 35 ± 5 min eating. Ad-shGK-EGFP-injected animals spent 78 ± 22 min eating, which was highly 
significant compared with both control groups, no differences were observed between control groups, suggesting 
Figure 5. Expression of neuropeptides involved in feeding regulation. (A–D) Control (Ad-shβGal-EGFP-
injected animals) and AdshGK-injected animals (Ad-shGK) were subjected to a 24-h fasting period. After that, 
saline or D-glucose was injected into the 3 V. After 2 h, NPY (A), AgRP (B), POMC (C) and CART (D) mRNA 
levels were assessed via qRT-PCR. Data are relative to cyclophilin (media ± SEM; n = 6) and processed by the 
ΔΔCT method. Statistics: Non-parametric ANOVA; *p < 0.05.
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a recuperation of the feeding behavior (Fig. 6B). The meal frequency in GK knockdown animals (expressed as a 
number of meal events in 12 h) was approximately double the frequency found in the control groups (Fig. 6C). 
In addition, the cumulative eating time was also increased in Ad-shGK-EGFP-injected animals (Fig. 6D). 
Although the number of intervals was not affected (Fig. 6E), the interval duration per animal was decreased 
Figure 6. Effect of GK knockdown on feeding behavior in control and GK knockdown animals. (A–F) Food 
intake (A), first meal duration (B), frequency of eating events (C), cumulative eating time (D), intervals and 
interval duration (F) were evaluated in unoperated, Ad-EGFP-injected (Ad-EGFP) and Ad-shGK-injected 
animals (Ad-shGK). Schematic representation of the experimental procedure is shown in the top. Statistics: 
non-parametric ANOVA; **p < 0.01.
www.nature.com/scientificreports/
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in GK knockdown animals, indicating a decreased satiety in this group (Fig. 6F). No differences were detected 
between non-injected and Ad-shβGal-EGFP-injected animals in all parameters.
Discussion
The hypothalamus is involved in the control of feeding behavior due to its ability to detect and respond to 
changes in blood glucose levels30. Particularly the AN, which is located in the basal region of the hypothalamus, 
is proximal to the ME, a circumventricular organ known to play an important role in homeostatic regulation31. 
Interestingly, tanycytes link the ventricular and the vascular compartments of the ME and regulate the permea-
bility properties of the fenestrated capillaries of the ME31. Unlike the fenestrated portal vessels of the ME, which 
are permeable to molecules coming from the bloodstream, adjacent tanycytes present various types of tight junc-
tions, which prevent diffusion of substances to the rest of the brain through the CSF. In this manner, blood-borne 
molecules enter the parenchyma of ME through the permeable vessels, and β2-tanycytes control their diffusion 
to the CSF via their tight junctions31. A different subpopulation of tanycytes, β1-tanycytes, is in close contact with 
hypothalamic neurons, particularly with the glucose-responsive populations of the AN. This particular distribu-
tion of hypothalamic tanycytes represents a key point in the regulation of food intake, and we have previously 
demonstrated that tanycytes express GLUT2 in their proximal pole (in contact with CSF) as well as GK and 
ATP-sensitive potassium (KATP) channels12.
GK, which catalyzes the high-Km phosphorylation of glucose, is a crucial enzyme in glucose homeostasis 
in different tissues involved in glucosensing. It is important to highlight that hexokinase I is also expressed in 
glucose-sensing cells from the VMH. However, its higher affinity for glucose (Km of 1 mM) and kinetic properties 
prevent hexokinase I from modulating its activity according to changes in glucose levels. Therefore, hexokinase 
I from the VMH seems to be involved in the continuous generation of ATP regardless of changes in extracellular 
glucose concentrations whereas GK acts as a glucose sensor32, 33. Studies in GK heterozygous knockout mice have 
attributed a major role for GK in food intake as well as in reproductive functions34. In a manner similar to that 
reported for pancreatic β-cells, GK is required for active glycolysis in β1-tanycytes. An increase in glucose con-
centration generates an enhanced glycolytic flux, which leads to ATP release in cultured tanycytes3. ATP activates 
P2Y receptors, which provokes an increase in cytosolic calcium levels at the expense of intracellular calcium 
sources3. Interestingly, ATP release and intracellular calcium increase were inhibited in experiments carried out 
with alloxan, a GK pharmacological inhibitor, demonstrating the importance of GK in this glucose-driven sign-
aling mechanism3.
Based on this mounting evidence, the aim of the present study was to knock down GK expression in tany-
cytes and evaluate the effects of GK suppression on feeding behavior. For this purpose, we generated a GK 
shRNA-containing adenovirus. Building on the success of previous studies from our laboratory demonstrating 
the inhibition of hypothalamic MCT1 mRNA expression using adenovirus-mediated transduction of a shRNA 
into the 3V and its effects on food intake, we focused on the use of this experimental tool in the present study29. 
We demonstrated that the adenoviral vectors selectively and effectively transduced tanycytes from the basal 
wall of the 3V, which is similar to Xu et al.35 and Elizondo et al.29. Additionally, we confirmed that GK mRNA 
expression was inhibited by 75% with respect to the control. Interestingly, we observed that GK knockdown 
increased food intake and altered feeding behavior, which is in accordance with a previous study showing that 
4V injection of alloxan provokes an increase in food intake36. Alloxan is a β-cytotoxic toxic glucose analogue 
and is commonly used for the development of animal model of Type-I Diabetes Mellitus37. Alloxan is rapidly 
taken up by the pancreatic β-cells through GLUT238. Subsequent studies showed alloxan injected into 3V but 
not 4V produced a decreased food intake and an altered glucoprivic response, which was accompanied by 
a massive loss of tanycytes and a decrease in orexigenic NPY23, which is related to the presence of GLUT2 
in the tanycytes12. We could not assess whether the adenovirus reaches more distant brain regions. Further 
studies are required to analyze whether adenovirus-mediated GK suppression affects the dorsal vagal complex, 
another cerebral region with important functions as central glucosensing functions39, 40. Importantly, it has 
recently been described that neurons in the nucleus of the solitary tract respond to acutely altered glucose 
concentration with either increases or decreases in neural excitability and altered synaptic input24, 39, which are 
GK-dependent40.
The levels of the anorexigenic peptides, POMC and CART, are known to increase in hyperglycemic con-
ditions, whereas the levels of the orexigenic peptides, NPY and AgRP, decrease in the same conditions. Our 
results confirmed this pattern of neuropeptide expression in glucose-challenged control rats. However, 
no differences in the expression of AgRP, NPY and CART were observed between the saline-treated and 
glucose-treated GK knockdown animals. Interestingly, POMC expression actually decreased in glucose-treated 
GK knockdown animals. These results are congruent to (and may be the cause of) the augmented food intake 
as well as the decreased satiety observed in the GK knockdown animals in our study. However, GK inhibition 
in the AN has recently been shown to decrease food intake in rats25. These findings may indicate that the 
role of GK on food intake is cell type-dependent in a manner similar to that observed for GKRP, which is 
present in tanycytes, and exerts opposing effects on GK compartmentalization compared to that observed in 
hepatocytes15.
Abnormal feeding initiation and termination after fasting periods due to a failure in the glucosensing mech-
anism has been reported for GLUT2-knockout mice subjected to fasting/feeding cycles28. GLUT2-dependent 
sensors regulate glucagon secretion under glucoprivic conditions41. Thus, GLUT2 and GK expression in tany-
cytes may have important physiological consequences. A high Km for glucose transport and the presence of 
GK suggest that tanycytes may increase glucose uptake and metabolization rates proportionally to changes 
in blood glucose levels18. In this regard, GLUT2 is the only glucose transporter with a high Km that has been 
probed identified to have a role in glucosensing. Among the four known hexokinase isoforms, GK is the only 
one with a Km in the order of millimolar, which is necessary for participating in the glucosensing mechanism. 
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It is interesting to note the possibility that different populations of tanycytes could detect glucose differently. β2 
tanycytes contact not only de CSF but also the fenestrated capillaries (without barrier) of the median eminence, 
whereas β1 and α tanycytes processes contact blood vessels with barrier. In this regard, it has been demonstrated 
that β2 tanycytes are able to uptake hormones such a s ghrelin and leptin from the capillaries of the ME and 
then transfer them to β1 and α tanycytes, which release the hormones in close proximity to their target, the AN 
neurons42–44. Based on this evidence, it is feasible to propose that β2 tanycytes concentrate glucose in the CSF of 
the infundibular recess in order to be transferred to β1 and α tanycytes, being these populations the responsi-
ble of communicating glucose concentration to NA neurons. Of note, this glucosensing mechanism requires a 
rapid increase in CSF glucose levels, making it possible for the GK-positive glucosensing cells to generate acute 
responses.
For this reason, inhibition of GK expression in β1-tanycytes suppressed the glucosensing network, altering 
satiation and/or satiety signal processing by neurons from the AN. These results, together with those shown by 
Elizondo et al.29 in MCT1 knockdown animals, represent a clear evidence of the metabolic coupling existing 
between tanycytes and neurons. In this metabolic interaction, tanycytes would metabolize glucose to lactate, 
and the lactate released by tanycytes could be sensed by neurons as a measure of blood glucose concentration 
(Fig. 7). It is possible that the astrocyte-neuron lactate shuttle could work as a compensating mechanism 
for GK inhibition. However, our results indicate that it fails to completely compensate for the effect of GK 
inhibition.
In conclusion, this is the first evidence of a crucial role for tanycytic GK in feeding behavior and represents 
an important step in unraveling the hypothalamic glucosensing mechanism36 and the way this glucose sensor 
modulates food intake. These results open a new window in the search for therapeutic strategies for controlling 
feeding behavior and the treatment of obesity, including the function of the glial element.
Materials and Methods
Ethics statement. All animals were handled in strict accordance with the Animal Welfare Assurance (per-
mit number 2010101 A), and all animal work was approved by the appropriate Ethics and Animal Care and Use 
Committee of the Universidad de Concepción, Chile. Fifty-six male adult Sprague-Dawley rats of 250–300 g were 
used in all experiments. Animals were housed in a separate animal room with constant temperature (21 ± 2 °C) 
and a controlled 12-h light/12-h dark cycle; lights were turned on every day at 7:00 a.m. Animals had free access 
to a standard rodent diet (Lab Diet, 5P00 Prolab RMH 3000, Purina Mills, St. Louis, MO) and tap water.
Figure 7. Hypothalamic glucosensing and its inhibition by GK knockdown in tanycytes. Model of glucosensing 
based on the metabolic interaction between tanycytes and AN neurons. Tanycytes are a specialized ependymal 
cell, localized in the lower parts of the ventricular walls and the floor of the 3V. α and β1-tanycytes line the 
infundibular recess, and their basal projections reach orexigenic and anorexigenic AN neurons. β2-tanycytes 
cover the floor of the 3V and extend their projections inside the ME and regulate the permeability properties 
of the fenestrated capillaries of the ME. Hyperglycemia results in increased glucose concentrations in the 3V, 
which affects GK-positive β1-tanycytes. These glial cells sense the increased glucose by the presence of GLUT2 
and GK. The GK activity could be regulated by GKRP and its nuclear compartmentalization. Lactate released by 
tanycytes could activate neurons of AN, generating a satiety response. GK inhibition represses the glucosensing 
circuit, causing an altered feeding behavior. 3V, third ventricle; ME, median eminence; CSF, cerebrospinal fluid; 
GK, glucokinase; AN, arcuate nucleus; MCT, monocarboxylate transporter.
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Preparations of adenovirus expressing shRNA specific for GK (Ad-shGK). Serotype 5 ΔE1, 
E3 based replication-deficient adenoviruses were generated as previously described29. Briefly, oligonucleo-
tides targeting rat GK were designed and selected using the Genebank accession number, L38990. Sense 
shRNA-GK 5′-TCA GAG TGA TGC TGG TCA A-3′ and antisense shRNA-GK 5′-TTG ACC AGC ATC 
ACT CTG A-3′ sequences shared no homology with other rat coding sequences by BLAST analysis. A ring 
sequence of nine base pairs (TTC AAG AGA) existed between the sense and antisense strands. Control 
shRNA oligonucleotides were designed and selected to target β-galactosidase from E. coli: sense5′-CGC GCC 
AAG GCC AGA CGC GAA TTA TTT CAA GAG AAT AAT TCG CGT CTG GCC TTT TTT TTT TAA 
T-3′ and antisense 5′-TAA AAA AAA AAG GCC AGA CGC GAA TTA TTC TCT TGA AAT AAT TCG 
CGT CTG GCC TTG G-3′. The expression cassette was then cloned into the adenoviral shuttle vector. All 
shRNAs (Invitrogen, Rockville, MD, USA) were synthesized and designed to contain both AscI and PacI 
restriction enzyme sites (New England Biolabs, Ipswich, MA, USA), which were used to ligate them into 
the plasmid, pDC311.2-OFF-EGFP downstream of the human H1 promoter, as previously described29. The 
plasmid was then cotransfected with the Ad genomic plasmid, pBHGlox∆E1,3Cre (Admax system, Microbix 
Biosystems, Ontario, Canada) into HEK293A cells. Virus particles were released by heat shock, and cell 
debris was removed by centrifugation for 5 min at 5000× g. The particles were recovered from the super-
natant by filtration through a 0.45-µm filter. The resulting adenoviral expression vectors (Ad-shGK-EGFP 
and Ad-shβGal-EGFP) were tittered by EGFP expression using the Adeno-XTM Rapid Titer Kit Protocol 
(Clontech, Mountain View, CA, USA).
Cannula implantation. Rats were handled everyday for one week prior to the experiments to get used to 
the researchers and the experimental procedures. Rats were anesthetized with an intraperitoneal injection of 
ketamine (90 mg/kg) and xylazine (10 mg/kg). The fur at the top of the head was removed to expose the area to 
be incised. A hole was drilled in the skull, and a guide cannula (28 gauge stainless steel; Plastics One, Roanoke, 
VA) was stereotactically implanted in the 3V of the rat (anterior-posterior from bregma −3.14 mm, medial-lateral 
from midsaggital sinus 0.0, and dorsal-ventral from the top of the skull 9.2 mm). The guide cannula was secured 
to the skull using 3/32 mm mounting screws and dental acrylic. A removable dummy cannula (28 gauge stainless 
steel; Plastics One,) fit into the cannula guide and sealed the opening of the guide cannula throughout the exper-
iments except when it was removed for the injections. After the surgery, rats were single-housed and allowed to 
recover for 5 days before adenovirus injection.
Intracerebroventricular (i.c.v.) injections of adenoviruses and immunohistochemistry. Rats 
were anesthetized with isoflurane and then injected into the 3V with either 25 µL of the control Ad-shβGal-EGFP 
stock solution (108 IFU/mL) or 25 µL of the Ad-shGK-EGFP stock solution (2 × 108 IFU/mL) for the experimen-
tal group at 2.5 µL/min. We were not able to further concentrate the adenovirus in order to inject it in a lower 
volume. Brains were collected for immunohistochemistry at 18, 24 and 48 h. The rat brains were fixed in 4% par-
aformaldehyde (PFA) by immersion for 48 h. After fixation, thick frontal sections of the hypothalamus (40 µm) 
were cut with a cryostat and subsequently processed free-floating. Tissues were immunostained with mouse 
anti-vimentin (1:200, DAKO, Carpinteria, CA, USA), rabbit anti-glial fibrillary acidic protein (GFAP; 1:200, 
DAKO) and rabbit anti-NeuN (1:1000, Abcam, Cambridge, MA, USA) antibodies diluted in Tris-HCl buffer 
(pH 7.8) containing 8.4 mM sodium phosphate, 3.5 mM potassium phosphate, 120 mM sodium chloride, and 1% 
bovine serum albumin. Sections were incubated with the primary antibodies overnight at room temperature in 
a humid chamber. After extensive washing, sections were incubated for 2 h at room temperature with Cy2-,Cy3- 
or Cy5-labeled secondary antibodies (1:200; Jackson ImmunoResearch, West Grove, PA, USA). These samples 
were counterstained with the DNA stain TOPRO-3 (1:1000; Invitrogen). The slides were analyzed using confocal 
laser microscopy (LSM 700, Zeiss). Colocalization of different markers was assessed by measuring the Pearson’s 
correlation coefficient, Rr. An Rr value of ‘1’ indicates complete colocalization, and a Rr value of ‘0’ indicates no 
specific colocalization.
Quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR). The tissues were pro-
cessed for qRT-PCR analysis as previously described28, 29. Briefly, 48 h after adenovirus injection, rats were fasted 
for 24 h. After that, rats were anesthetized with isoflurane and i.c.v. injected with 10 μL of saline buffer (128 mM 
NaCl, 3 mM KCl, 1.3 mM CaCl2, 1.0 mM MgCl2, 1.3 mM NaH2PO4, 21 mM Na2HPO4, pH 7.4 and 320 mOsm) or 
10 μL of 50 mM D-glucose diluted in the same buffer (320 mOsm, pH 7.4) at a rate of 2.5 μL/min. Hypothalamic 
samples were collected 2 h post-glucose or saline injection for the mRNA analysis expression. qRT-PCR analysis 
was used to measure the expression of hypothalamic cyclophilin (the housekeeping gene), GK, NPY, CART, 
POMC and AgRP. After the experimental treatments, the brain of each rat (six per condition) was removed, and 
the hypothalamic area was isolated and further dissected to obtain a region close to the 3V ependymal layer. 
All microdissections were performed closest to the basal 3V and under a stereomicroscope Leica M80 (Leica, 
Wetzlar, Germany). Total RNA from hypothalamus was isolated using TRIzol (Invitrogen) and treated with 
DNase I (Fermentas International INC, Burlington, Ontario, Canada) to remove genomic DNA contamination. 
A total of 2 µg of RNA from each sample was reverse transcribed into cDNA according to the manufacturer’s pro-
tocol of M-MULV reverse transcriptase (Fermentas International INC). Parallel reactions were performed in the 
absence of reverse transcriptase to control for the presence of genomic DNA. qRT-PCR reactions were prepared 
with a Brilliant II SYBR Green QPCR Master Mix kit (Agilent Technologies, Inc., Santa Clara, CA, USA) in a final 
volume of 12.5 µL containing 1x SYBR green Master Mix, 1 µL cDNA sample and 500 nM of the following sets of 
primers: cyclophilin, sense 5′-ATA ATG GCA CTG GTG GCA AGT C-3′ and antisense 5′ATT CCT GGA CCC 
AAA ACG CTC C3′ (expected product of 239 bp); GK, sense 5′AAA GAT GTT GCC CAC CTA CGT GCG3′ 
and antisense 5′ATC ATG CCG ACC TCA CAT TGG C3′ (expected product of 510 bp); NPY, sense 5′-TGT TTG 
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GGC ATT CTG GCT GAG G-3′ and antisense 5′- CTG GGG GCA TTT TCT GTG CTT TC-3′ (expected prod-
uct of 203 bp); AgRP, sense 5′GCA GAC CGA GCA GAA GAT GTT C3′and antisense 5′GTA GCA CGT CTT 
GAA GAA GC GG3′ (expected product of 186 bp); POMC, sense 5′CTC CTG CTT CAG ACC TCC ATA GAC3′ 
and antisense 5′AAG GGC TGT TCA TCT CCG TTG3′ (expected product of 164 bp) and CART, sense 5′TCT 
GGG AAG AAG AGG GAC TTT CGC3′and antisense 5′TCC ATT TGT GTT GCT TTG GGG TG3′ (expected 
product of 137 bp). All reactions were performed with an initial denaturation of 5 min at 95 °C, followed by 40 
cycles of 30 s at 95 °C, annealing for 30 s at 55 °C, and extension for 1 min at 72 °C in an Mx3000 P qPCR System 
(Agilent Technologies). Ct values of GK mRNA obtained from three different experiments were normalized 
according to the 2−ΔΔCt method, using cyclophilin as a reference gene45.
Immunoblotting. For protein analysis, hypothalamic samples were collected 48 h post-adenoviral injec-
tion. Rat hypothalamus was homogenized in buffer A (0.3 mM sucrose, 3 mM DTT, 1 mM EDTA, 100 μg/mL 
PMSF, 2 μg/mL pepstatin A, 2 μg/mL leupeptin and 2 μg/mL aprotinin) and sonicated three times on ice at 300 W 
(Sonics & Material INC, VCF1, Connecticut, USA) for 10 s. After centrifugation at 4,000× g for 10 min, the pro-
teins were resolved by SDS-PAGE (50 µg/lane) in a 12% (w/v) polyacrylamide gel, transferred to PVDF mem-
branes (0.45 µm pore, Amersham Pharmacia Biotech., Piscataway, NJ, USA), and probed with rabbit anti-GK 
(1:100, Santa Cruz Biotechnology, CA, USA), rabbit anti-GKRP (Santa Cruz Biotechnology), rabbit anti-GLUT2 
(Alpha Diagnostics, 1:1000), rabbit anti-EGFP and anti-β-actin (1:1000) antibodies. After extensive washing, 
the PVDF membranes were incubated for 1 h at 4 °C with peroxidase-labeled anti-rabbit IgG (1:5000; Jackson 
ImmunoResearch). The reaction was developed using an enhanced chemiluminescence (ECL) Western blotting 
analysis system (Amersham Biosciences). Negative controls consisted of incubating the membrane in the absence 
of anti-GK. The images shown are representative of at least three analyses performed on samples from at least 
three separate experiments. β-actin expression levels were used as a loading control, and GFP expression levels 
were used as a transduction control.
Food intake monitoring and feeding behavior analysis. At 24 h post-adenoviral injection, rats were 
subjected to a 24 h fasting period followed by a 12 h refeeding period for the feeding behavior analysis. Food 
intake was monitored during the refeeding period by providing rats with pre-weighed rat chow and weighing it 
again after 12 h (Fig. 6, schematic representation). Food intake was expressed as g consumed per 200 g of body 
weight. Every interaction with the feeder was recorded by a computerized data acquisition system (VitalView, 
Respironics, Inc., Murraysville, PA, USA), registering frequency and time of permanency in the feeder.
A meal was considered when the bouts were larger than 10 s into the feeder, and these meals were separated 
from other feeding bouts by more than 10 min of inter-meal interval46, 47. Except for the first meal, when a bout 
was longer than 30 min, two meals were considered. The meal patterns calculated included the following: dura-
tion of the first meal (in min), frequency of meals (in number of meals in 12 h), cumulative eating time as the 
total time spent in the feeder (in min), duration of inter-meal intervals (in min), and number of meal intervals. 
The inter-meal interval was calculated as the time period between the end of one meal and the initiation of the 
next one. The mean meal size was determined as the total food intake (g) divided by frequency. The mean meal 
duration was calculated by dividing the total meal duration (in min) by meal frequency, and the eating rate was 
estimated dividing total food intake (mg) by meal duration (min).
Statistical analyses. For each data group, results were expressed as mean ± standard error of the mean 
(SEM), and n refers to the number of animals that were used. For statistical analysis, each treatment was 
compared with its respective control. Differences between two groups were assessed using the Student t-test. 
Differences between more than two groups were assessed using ANOVA. Differences were considered significant 
when P < 0.05. The statistical analyses were performed using GraphPad Prism 5.0 Software (GraphPad Software 
Inc., San Diego, CA, USA).
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